Evidence map›Paper›PMID 34913249›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Relating Conformational Equilibria to Conformer-Specific Lipophilicities: New Opportunities in Drug Discovery.

Bruno Linclau, Zhong Wang, Benjamin Jeffries, Jérôme Graton, Rodrigo J Carbajo, Davy Sinnaeve, Jean-Yves Le Questel, James S Scott, Elisabetta Chiarparin

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bruno LinclauSchool of Chemistry, University of Southampton, Highfield, Southampton, SO17 1BJ, UK.ORCID 0000-0001-8762-0170
Zhong WangSchool of Chemistry, University of Southampton, Highfield, Southampton, SO17 1BJ, UK.ORCID 0000-0002-6144-4022
Benjamin JeffriesSchool of Chemistry, University of Southampton, Highfield, Southampton, SO17 1BJ, UK.
Jérôme GratonCEISAM UMR CNRS 6230, Université de Nantes, CNRS, CEISAM UMR 6230, 44000, Nantes, France.
Rodrigo J CarbajoMedicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, UK.
Davy SinnaeveUniv. Lille, Inserm, Institut Pasteur de Lille, CHU Lille, U1167-RID-AGE-Risk Factors and Molecular, Determinants of Aging-Related Diseases, 59000, Lille, France.
Jean-Yves Le QuestelCEISAM UMR CNRS 6230, Université de Nantes, CNRS, CEISAM UMR 6230, 44000, Nantes, France.
James S ScottMedicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, UK.
Elisabetta ChiarparinMedicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, UK.

Funding

AstraZeneca UKEngineering and Physical Sciences Research Council EP/K039466/1Engineering and Physical Sciences Research Council EP/M50662X/1Engineering and Physical Sciences Research Council EP/M508147/1Engineering and Physical Sciences Research Council EP/P019943/1Fonds Wetenschappelijk Onderzoek G0F5621N
6 · The paper itself

Abstract

Efficient drug discovery is based on a concerted effort in optimizing bioactivity and compound properties such as lipophilicity, and is guided by efficiency metrics that reflect both aspects. While conformation-activity relationships and ligand conformational control are known strategies to improve bioactivity, the use of conformer-specific lipophilicities (logp) is much less explored. Here we show how conformer-specific logp values can be obtained from knowledge of the macroscopic logP value, and of the equilibrium constants between the individual species in water and in octanol. This is illustrated with fluorinated amide rotamers, with integration of rotamer

Indexed as

Drug DiscoveryHydrophobic and Hydrophilic InteractionsOctanolsPharmaceutical PreparationsWaterOctanolsPharmaceutical PreparationsWaterAmidesConformationDrug DevelopmentLipophilicityNMR Spectroscopy

Identifiers

PMID34913249
PMCPMC9304282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.